Radiofrequency Therapy
Device
Abbott Laboratories
Total Payments
$52,999
Transactions
920
Doctors
528
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $4,873 | 183 | 148 |
| 2017 | $48,126 | 737 | 431 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,154 | 21 | 49.3% |
| Food and Beverage | $24,301 | 881 | 45.9% |
| Education | $1,510 | 9 | 2.8% |
| Travel and Lodging | $1,034 | 9 | 2.0% |
Ad
Manufacturing Companies
- Abbott Laboratories $52,999
Product Information
- Type Device
- Total Payments $52,999
- Total Doctors 528
- Transactions 920
About Radiofrequency Therapy
Radiofrequency Therapy is a device associated with $52,999 in payments to 528 healthcare providers, recorded across 920 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2017 to 2018. In 2018, $4,873 was paid across 183 transactions to 148 doctors.
The most common payment nature for Radiofrequency Therapy is "Consulting Fee" ($26,154, 49.3% of total).